Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?
| Autor: | Lena J Al-Dujaili, Harris E. McFerrin, Emily D. Varnell, Patrick P Clerkin, James M. Hill, Partha S. Bhattacharjee, Herbert E. Kaufman, Christian Clement |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Microbiology (medical)
Gene Expression Regulation Viral medicine.medical_treatment viruses Virulence Herpesvirus 1 Human Biology medicine.disease_cause Microbiology Asymptomatic Antiviral Agents Virus Article Keratitis Recurrence Virus latency medicine Humans Chemotherapy Virus Activation medicine.disease Virology Virus Latency Herpes simplex virus Immunology Keratitis Herpetic medicine.symptom |
| Zdroj: | Future microbiology. 6(8) |
| ISSN: | 1746-0921 |
| Popis: | Most humans are infected with herpes simplex virus (HSV) type 1 in early childhood and remain latently infected throughout life. While most individuals have mild or no symptoms, some will develop destructive HSV keratitis. Ocular infection with HSV-1 and its associated sequelae account for the majority of corneal blindness in industrialized nations. Neuronal latency in the peripheral ganglia is established when transcription of the viral genome is repressed (silenced) except for the latency-associated transcripts and microRNAs. The functions of latency-associated transcripts have been investigated since 1987. Roles have been suggested relating to reactivation, establishment of latency, neuronal protection, antiapoptosis, apoptosis, virulence and asymptomatic shedding. Here, we review HSV-1 latent infections, reactivation, recurrent disease and antiviral therapies for the ocular HSV diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|